Topical bethanechol for the improvement of esophageal dysmotility: A pilot study

Annals of Otology, Rhinology and Laryngology

Volumn 122, Issue 8, 2013, Pages 481-486

  O'Rourke, Ashli ^a   Weinberger, Paul ^a   Morrison, Michele ^b   Conklin, Jeffrey ^c   Postma, Gregory ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Bethanechol; Dysphagia; Esophageal dysmotility; Esophageal hypoperistalsis; High resolution manometry; Ineffective esophageal motility

Indexed keywords

BETHANECHOL;

ACCLIMATIZATION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ESOPHAGUS DISEASE; ESOPHAGUS DYSMOTILITY; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; HUMAN; MALE; MOTOR PERFORMANCE; NOSE CAVITY; PILOT STUDY; PRIORITY JOURNAL; SMOOTH MUSCLE; SWALLOWING;

EID: 84883040348     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348941312200801     Document Type: Article

References (19)

1. Conchillo JM, Nguyen NQ, Samsom M, Holloway RH, Smout AJ. Multichannel intraluminal impedance monitoring in the evaluation of patients with non-obstructive dysphagia. Am J Gastroenterol 2005;100:2624-32.
2. Tutuian R, Castell DO. Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol 2004;99:1011-9.
3. Dekel R, Pearson T, Wendel C, De Garmo P, Fennerty MB, Fass R. Assessment of oesophageal motor function in patients with dysphagia or chest pain - the Clinical Outcomes Research Initiative experience. Aliment Pharmacol Ther 2003;18:1083-9.
4. Fouad YM, Katz PO, Hatlebakk JG, Castell DO. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol 1999;94:1464-7.
5. Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut 2001;49:145-51.
6. Pandolfino JE, Fox MR, Bredenoord AJ, Kahrilas PJ. High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. Neurogastroenterol Motil 2009;21:796-806.
7. Bulsiewicz WJ, Kahrilas PJ, Kwiatek MA, Ghosh SK, Meek A, Pandolfino JE. Esophageal pressure topography criteria indicative of incomplete bolus clearance: a study using highresolution impedance manometry. Am J Gastroenterol 2009;104:2721-8.
8. Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988;94:73-80.
9. Bredenoord AJ, Fox M, Kahrilas PJ, Pandolfino JE, Schwizer W, Smout AJ; International High Resolution Manometry Working Group. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil 2012;24(suppl 1):57-65.
10. Gidda JS, Buyniski JP. Swallow-evoked peristalsis in opossum esophagus: role of cholinergic mechanisms. Am J Physiol 1986;251:G779-G785.
11. Dodds WJ, Dent J, Hogan WJ, Arndorfer RC. Effect of atropine on esophageal motor function in humans. Am J Physiol 1981;240:G290-G296.
12. Holloway RH, Dodds WJ, Helm JF, Hogan WJ, Dent J, Arndorfer RC. Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 1986;90:924-9.
13. Song CW, Um SH, Kim CD, Ryu HS, Hyun JH, Choe JG. Double-blind placebo-controlled study of cisapride in patients with nonspecific esophageal motility disorder accompanied by delayed esophageal transit. Scand J Gastroenterol 1997;32:541-6.
14. Michalets EL, Williams CR. Drug interactions with cisapride: clinical implications. Clin Pharmacokinet 2000;39:49-75.
15. Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol 2009;43:253-60.
16. Di Stefano M, Vos R, Sifrim D, et al. Effect of buspirone, a 5 HT1A receptor agonist, on oesophageal peristalsis and lower esophageal sphincter function in healthy volunteers [Abstract]. Gastroenterology 2004;126:A-638.
17. Hammer D. Gastroesophageal reflux and prokinetic agents. Neonatal Netw 2005;24:51-62.
18. Humphries TJ, Castell DO. Effect of oral bethanechol on parameters of esophageal peristalsis. Dig Dis Sci 1981;26:129-32.
19. Agrawal A, Hila A, Tutuian R, Mainie I, Castell DO. Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility. J Clin Gastroenterol 2007;41:366-70.